Search

Search any products, services and so on here.

About 16311 result(s)

Global Triptorelin Drug Market Research Report 2024

  • Jan 18, 24
  • ID: 3156
  • Pages: 86
  • Figures: 193
  • Views: 22
  • From $2,900

Triptorelin, the active substance of Decapeptyl®/Trelstar®/Pamorelin®/Triptodur®, is a GnRH agonist analogue. An agonist is a chemical that binds to a receptor of a cell and triggers a response by that cell. Triptorelin decreases the serum testosterone to castrate levels (estradiol in females). The global Triptorelin Drug market was valued at US$ 320 million in 2023 and is anticipated to reach US...


Global Zonisamide Market Research Report 2024

  • Jan 18, 24
  • ID: 3158
  • Pages: 93
  • Figures: 205
  • Views: 21
  • From $2,900

Zonisamide is a medication used to treat the symptoms of epilepsy and Parkinson's disease. The global Zonisamide market was valued at US$ 489 million in 2023 and is anticipated to reach US$ 718.8 million by 2030, witnessing a CAGR of 6.2% during the forecast period 2024-2030. North American market for Zonisamide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAG...


Global Antihemophilic Factor Drug Market Research Report 2024

  • Jan 18, 24
  • ID: 3159
  • Pages: 89
  • Figures: 205
  • Views: 23
  • From $2,900

Antihemophilic Factor Drug is used to control and prevent bleeding episodes in people with low levels of factor VIII (hemophilia A). It is also used in these patients before surgery to prevent bleeding. The global Antihemophilic Factor Drug market was valued at US$ 541 million in 2023 and is anticipated to reach US$ 796 million by 2030, witnessing a CAGR of 6.1% during the forecast period 2024-20...


Global Cevimeline Market Research Report 2024

  • Jan 18, 24
  • ID: 3160
  • Pages: 77
  • Figures: 180
  • Views: 22
  • From $2,900

Cevimeline (trade name Evoxac) is a parasympathomimetic and muscarinic agonist, with particular effect on M1 and M3 receptors. It is used in the treatment of dry mouth and especially associated with Sjögren's syndrome. The global Cevimeline market was valued at US$ 214 million in 2023 and is anticipated to reach US$ 325.3 million by 2030, witnessing a CAGR of 6.1% during the forecast period 2024-...


Global Clotrimazole and Betamethasone Diproprionate Market Research Report 2024

  • Jan 18, 24
  • ID: 3161
  • Pages: 84
  • Figures: 178
  • Views: 21
  • From $2,900

Clotrimazole and Betamethasone diproprionate is a prescription medication used on the skin (topical) to treat fungal infections of the feet, groin, and body in people 17 years of age and older. The global Clotrimazole and Betamethasone Diproprionate market was valued at US$ 134 million in 2023 and is anticipated to reach US$ 215.2 million by 2030, witnessing a CAGR of 6.2% during the forecast per...


Global Atovaquone and Proguanil Market Research Report 2024

  • Jan 18, 24
  • ID: 3162
  • Pages: 76
  • Figures: 164
  • Views: 22
  • From $2,900

Atovaquone/Proguanil Hydrochloride is a dose combination of atovaquone and proguanil hydrochloride which acts as a blood schizonticide and also has activity against hepatic schizonts of Plasmodium falciparum. The global Atovaquone and Proguanil market was valued at US$ 129 million in 2023 and is anticipated to reach US$ 191.2 million by 2030, witnessing a CAGR of 6.1% during the forecast period 2...


Global Atovaquone Market Research Report 2024

  • Jan 18, 24
  • ID: 3163
  • Pages: 68
  • Figures: 159
  • Views: 21
  • From $2,900

Atovaquone is used to prevent or treat a serious lung infection called Pneumocystis pneumonia (PCP). This medication helps to stop infection symptoms such as fever, cough, tiredness, and shortness of breath. The global Atovaquone market was valued at US$ 185 million in 2023 and is anticipated to reach US$ 282.6 million by 2030, witnessing a CAGR of 6.2% during the forecast period 2024-2030. Nort...


Global Temsirolimus Market Research Report 2024

  • Jan 18, 24
  • ID: 3164
  • Pages: 71
  • Figures: 147
  • Views: 19
  • From $2,900

Temsirolimus injection is used to treat advanced kidney cancer. The global Temsirolimus market was valued at US$ 145 million in 2023 and is anticipated to reach US$ 226.7 million by 2030, witnessing a CAGR of 6.2% during the forecast period 2024-2030. North American market for Temsirolimus is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forec...


Global Valsartan Drug Market Research Report 2024

  • Jan 18, 24
  • ID: 3165
  • Pages: 101
  • Figures: 226
  • Views: 21
  • From $2,900

Valsartan (trade name Diovan, Novartis International AG) is mainly used for treatment of high blood pressure, congestive heart failure, and to increase the chances of living longer after a heart attack. It is an angiotensin II receptor antagonist (commonly called an ARB, or angiotensin receptor blocker), that is selective for the type I (AT1) angiotensin receptor. The global Valsartan Drug market...


Global Valsartan-Hydrochlorothiazide Market Research Report 2024

  • Jan 18, 24
  • ID: 3166
  • Pages: 98
  • Figures: 223
  • Views: 20
  • From $2,900

This drug is used to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This product contains two medications: valsartan and hydrochlorothiazide. Valsartan is an angiotensin receptor blocker (ARB) and works by relaxing blood vessels so that blood can flow more easily. Hydrochlorothiazide is a "water pill" (diuretic) that causes you to...


Our team would be happy to assist you with your queries.

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232